E. Al-jishi et al., Clinical, biochemical, and molecular characterization of patients with glutathione synthetase deficiency, CLIN GENET, 55(6), 1999, pp. 444-449
Citations number
20
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Molecular Biology & Genetics
Pyroglutamic aciduria (5-oxoprolinuria) is a rare autosomal recessive disor
der caused by either glutathione synthetase deficiency (GSSD) or 5-oxoproli
nase deficiency. GSSD results in low glutathione levels in erythrocytes and
may present with hemolytic anemia alone or together with pyroglutamic acid
uria, metabolic acidosis, and CNS damage. Five patients with pyroglutamic a
ciduria were studied. All presented with hemolytic anemia and metabolic aci
dosis. Two (brothers) also had Fanconi nephropathy, which is not seen in py
roglutamic aciduria. Molecular analyses of the GSS gene was performed in 3
patients. RT-PCR and heteroduplex analysis identified a homozygous deletion
in 1 patient and a homozygous mutation in 2 others (brothers with Fanconi
nephropathy). Sequencing of glutathione synthetase (GSS) cDNA from the firs
t patient showed a 141-bp deletion corresponding to the entire exon 4, whil
st the corresponding genomic DNA showed a G(491) --> A homozygous splice si
te mutation. Sequencing of GSS cDNA from the Fanconi nephropathy patients s
howed a C-847 --> T [ARG(283) --> CYS] mutation in exon 9.